Ion channel screening plates: design, construction, and maintenance
Ion channels have provided a diverse set of therapeutic targets across all areas of the pharmaceutical industry. Many companies are pursuing this unique class of targets for areas of unmet medical need such as neuropathic and inflammatory pains. In the past, focused library screening sets had been d...
Gespeichert in:
Veröffentlicht in: | Assay and drug development technologies 2010-08, Vol.8 (4), p.504-511 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 511 |
---|---|
container_issue | 4 |
container_start_page | 504 |
container_title | Assay and drug development technologies |
container_volume | 8 |
creator | Mayer, Scott C Butera, John A Diller, David J Dunlop, John Ellingboe, John Fan, Kristi Yi Kaftan, Edward Mekonnen, Belew Mobilio, Dominick Paslay, Jeff Tawa, Gregory Vasilyev, Dmitry Bowlby, Mark R |
description | Ion channels have provided a diverse set of therapeutic targets across all areas of the pharmaceutical industry. Many companies are pursuing this unique class of targets for areas of unmet medical need such as neuropathic and inflammatory pains. In the past, focused library screening sets had been designed for CNS and kinase targets. Our investigations were aimed at creating a similar dynamic screening set enriched for compounds targeting ion channels to aid screening efforts of this important class of targets. The key advantages of this approach for ion channel targets would be: (1) to identify tool compounds for novel targets and assist in assay validation, (2) to serve as a focused screen for non-384-well adaptable targets, and (3) to jump start a particular program, that is, catch-up to competition for validated, well-known targets. |
doi_str_mv | 10.1089/adt.2009.0239 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_817609710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A236390988</galeid><sourcerecordid>A236390988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-b91b6aa2f240fe584ce580020080d84d353ca1250a1d6e807311a1480f3253523</originalsourceid><addsrcrecordid>eNqFkU1rGzEQQEVpiR03x17DQg-5ZJ3R10rKLZgkNRh6aaA3IWtnXYVdrbNaH_rvq8VuIBAIAzMa8UYMeoR8o7CkoM2Nq8clAzBLYNx8InMqpSo1ZerzdBZQVlL_npHzlJ4BGHAlzsiMgVDABJ2T1bqPhf_jYsS2SH5AjCHuin3rRky3RY0p7OJ14fuYxuHgx9DnzsW66FyII0YXPX4lXxrXJrw41QV5erj_tfpRbn4-rld3m9JzocZya-i2co41TECDUguf07QTaKi1qLnk3lEmwdG6Qg2KU-qo0NBwJrlkfEGuju_uh_7lgGm0XUge29ZF7A_JaqoqMIrCh6QSBqhkzGTy-5HcuRZtiE0_Ds5PtL1jvOIGjNaZWr5D5aixC_lvsAn5_s1AeRzwQ5_SgI3dD6Fzw19LwU7ebPZmJ2928pb5y9PCh22H9Sv9XxT_B0bHj6U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749015229</pqid></control><display><type>article</type><title>Ion channel screening plates: design, construction, and maintenance</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Mayer, Scott C ; Butera, John A ; Diller, David J ; Dunlop, John ; Ellingboe, John ; Fan, Kristi Yi ; Kaftan, Edward ; Mekonnen, Belew ; Mobilio, Dominick ; Paslay, Jeff ; Tawa, Gregory ; Vasilyev, Dmitry ; Bowlby, Mark R</creator><creatorcontrib>Mayer, Scott C ; Butera, John A ; Diller, David J ; Dunlop, John ; Ellingboe, John ; Fan, Kristi Yi ; Kaftan, Edward ; Mekonnen, Belew ; Mobilio, Dominick ; Paslay, Jeff ; Tawa, Gregory ; Vasilyev, Dmitry ; Bowlby, Mark R</creatorcontrib><description>Ion channels have provided a diverse set of therapeutic targets across all areas of the pharmaceutical industry. Many companies are pursuing this unique class of targets for areas of unmet medical need such as neuropathic and inflammatory pains. In the past, focused library screening sets had been designed for CNS and kinase targets. Our investigations were aimed at creating a similar dynamic screening set enriched for compounds targeting ion channels to aid screening efforts of this important class of targets. The key advantages of this approach for ion channel targets would be: (1) to identify tool compounds for novel targets and assist in assay validation, (2) to serve as a focused screen for non-384-well adaptable targets, and (3) to jump start a particular program, that is, catch-up to competition for validated, well-known targets.</description><identifier>ISSN: 1540-658X</identifier><identifier>EISSN: 1557-8127</identifier><identifier>DOI: 10.1089/adt.2009.0239</identifier><identifier>PMID: 20470241</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Drug Design ; Drug Evaluation, Preclinical - methods ; Drugs ; Gene expression ; Genetic aspects ; Ion Channel Gating ; Ion channels ; Ion Channels - analysis ; Ion Channels - metabolism ; Models, Molecular ; Molecular Targeted Therapy ; Physiological aspects ; Product/Service Evaluations ; Small Molecule Libraries</subject><ispartof>Assay and drug development technologies, 2010-08, Vol.8 (4), p.504-511</ispartof><rights>COPYRIGHT 2010 Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-b91b6aa2f240fe584ce580020080d84d353ca1250a1d6e807311a1480f3253523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20470241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayer, Scott C</creatorcontrib><creatorcontrib>Butera, John A</creatorcontrib><creatorcontrib>Diller, David J</creatorcontrib><creatorcontrib>Dunlop, John</creatorcontrib><creatorcontrib>Ellingboe, John</creatorcontrib><creatorcontrib>Fan, Kristi Yi</creatorcontrib><creatorcontrib>Kaftan, Edward</creatorcontrib><creatorcontrib>Mekonnen, Belew</creatorcontrib><creatorcontrib>Mobilio, Dominick</creatorcontrib><creatorcontrib>Paslay, Jeff</creatorcontrib><creatorcontrib>Tawa, Gregory</creatorcontrib><creatorcontrib>Vasilyev, Dmitry</creatorcontrib><creatorcontrib>Bowlby, Mark R</creatorcontrib><title>Ion channel screening plates: design, construction, and maintenance</title><title>Assay and drug development technologies</title><addtitle>Assay Drug Dev Technol</addtitle><description>Ion channels have provided a diverse set of therapeutic targets across all areas of the pharmaceutical industry. Many companies are pursuing this unique class of targets for areas of unmet medical need such as neuropathic and inflammatory pains. In the past, focused library screening sets had been designed for CNS and kinase targets. Our investigations were aimed at creating a similar dynamic screening set enriched for compounds targeting ion channels to aid screening efforts of this important class of targets. The key advantages of this approach for ion channel targets would be: (1) to identify tool compounds for novel targets and assist in assay validation, (2) to serve as a focused screen for non-384-well adaptable targets, and (3) to jump start a particular program, that is, catch-up to competition for validated, well-known targets.</description><subject>Drug Design</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Drugs</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Ion Channel Gating</subject><subject>Ion channels</subject><subject>Ion Channels - analysis</subject><subject>Ion Channels - metabolism</subject><subject>Models, Molecular</subject><subject>Molecular Targeted Therapy</subject><subject>Physiological aspects</subject><subject>Product/Service Evaluations</subject><subject>Small Molecule Libraries</subject><issn>1540-658X</issn><issn>1557-8127</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rGzEQQEVpiR03x17DQg-5ZJ3R10rKLZgkNRh6aaA3IWtnXYVdrbNaH_rvq8VuIBAIAzMa8UYMeoR8o7CkoM2Nq8clAzBLYNx8InMqpSo1ZerzdBZQVlL_npHzlJ4BGHAlzsiMgVDABJ2T1bqPhf_jYsS2SH5AjCHuin3rRky3RY0p7OJ14fuYxuHgx9DnzsW66FyII0YXPX4lXxrXJrw41QV5erj_tfpRbn4-rld3m9JzocZya-i2co41TECDUguf07QTaKi1qLnk3lEmwdG6Qg2KU-qo0NBwJrlkfEGuju_uh_7lgGm0XUge29ZF7A_JaqoqMIrCh6QSBqhkzGTy-5HcuRZtiE0_Ds5PtL1jvOIGjNaZWr5D5aixC_lvsAn5_s1AeRzwQ5_SgI3dD6Fzw19LwU7ebPZmJ2928pb5y9PCh22H9Sv9XxT_B0bHj6U</recordid><startdate>201008</startdate><enddate>201008</enddate><creator>Mayer, Scott C</creator><creator>Butera, John A</creator><creator>Diller, David J</creator><creator>Dunlop, John</creator><creator>Ellingboe, John</creator><creator>Fan, Kristi Yi</creator><creator>Kaftan, Edward</creator><creator>Mekonnen, Belew</creator><creator>Mobilio, Dominick</creator><creator>Paslay, Jeff</creator><creator>Tawa, Gregory</creator><creator>Vasilyev, Dmitry</creator><creator>Bowlby, Mark R</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>201008</creationdate><title>Ion channel screening plates: design, construction, and maintenance</title><author>Mayer, Scott C ; Butera, John A ; Diller, David J ; Dunlop, John ; Ellingboe, John ; Fan, Kristi Yi ; Kaftan, Edward ; Mekonnen, Belew ; Mobilio, Dominick ; Paslay, Jeff ; Tawa, Gregory ; Vasilyev, Dmitry ; Bowlby, Mark R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-b91b6aa2f240fe584ce580020080d84d353ca1250a1d6e807311a1480f3253523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Drug Design</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Drugs</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Ion Channel Gating</topic><topic>Ion channels</topic><topic>Ion Channels - analysis</topic><topic>Ion Channels - metabolism</topic><topic>Models, Molecular</topic><topic>Molecular Targeted Therapy</topic><topic>Physiological aspects</topic><topic>Product/Service Evaluations</topic><topic>Small Molecule Libraries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayer, Scott C</creatorcontrib><creatorcontrib>Butera, John A</creatorcontrib><creatorcontrib>Diller, David J</creatorcontrib><creatorcontrib>Dunlop, John</creatorcontrib><creatorcontrib>Ellingboe, John</creatorcontrib><creatorcontrib>Fan, Kristi Yi</creatorcontrib><creatorcontrib>Kaftan, Edward</creatorcontrib><creatorcontrib>Mekonnen, Belew</creatorcontrib><creatorcontrib>Mobilio, Dominick</creatorcontrib><creatorcontrib>Paslay, Jeff</creatorcontrib><creatorcontrib>Tawa, Gregory</creatorcontrib><creatorcontrib>Vasilyev, Dmitry</creatorcontrib><creatorcontrib>Bowlby, Mark R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Assay and drug development technologies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayer, Scott C</au><au>Butera, John A</au><au>Diller, David J</au><au>Dunlop, John</au><au>Ellingboe, John</au><au>Fan, Kristi Yi</au><au>Kaftan, Edward</au><au>Mekonnen, Belew</au><au>Mobilio, Dominick</au><au>Paslay, Jeff</au><au>Tawa, Gregory</au><au>Vasilyev, Dmitry</au><au>Bowlby, Mark R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ion channel screening plates: design, construction, and maintenance</atitle><jtitle>Assay and drug development technologies</jtitle><addtitle>Assay Drug Dev Technol</addtitle><date>2010-08</date><risdate>2010</risdate><volume>8</volume><issue>4</issue><spage>504</spage><epage>511</epage><pages>504-511</pages><issn>1540-658X</issn><eissn>1557-8127</eissn><abstract>Ion channels have provided a diverse set of therapeutic targets across all areas of the pharmaceutical industry. Many companies are pursuing this unique class of targets for areas of unmet medical need such as neuropathic and inflammatory pains. In the past, focused library screening sets had been designed for CNS and kinase targets. Our investigations were aimed at creating a similar dynamic screening set enriched for compounds targeting ion channels to aid screening efforts of this important class of targets. The key advantages of this approach for ion channel targets would be: (1) to identify tool compounds for novel targets and assist in assay validation, (2) to serve as a focused screen for non-384-well adaptable targets, and (3) to jump start a particular program, that is, catch-up to competition for validated, well-known targets.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>20470241</pmid><doi>10.1089/adt.2009.0239</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1540-658X |
ispartof | Assay and drug development technologies, 2010-08, Vol.8 (4), p.504-511 |
issn | 1540-658X 1557-8127 |
language | eng |
recordid | cdi_proquest_miscellaneous_817609710 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Drug Design Drug Evaluation, Preclinical - methods Drugs Gene expression Genetic aspects Ion Channel Gating Ion channels Ion Channels - analysis Ion Channels - metabolism Models, Molecular Molecular Targeted Therapy Physiological aspects Product/Service Evaluations Small Molecule Libraries |
title | Ion channel screening plates: design, construction, and maintenance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T17%3A41%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ion%20channel%20screening%20plates:%20design,%20construction,%20and%20maintenance&rft.jtitle=Assay%20and%20drug%20development%20technologies&rft.au=Mayer,%20Scott%20C&rft.date=2010-08&rft.volume=8&rft.issue=4&rft.spage=504&rft.epage=511&rft.pages=504-511&rft.issn=1540-658X&rft.eissn=1557-8127&rft_id=info:doi/10.1089/adt.2009.0239&rft_dat=%3Cgale_proqu%3EA236390988%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749015229&rft_id=info:pmid/20470241&rft_galeid=A236390988&rfr_iscdi=true |